Item 5.07: Submission of Matters to a Vote of Security Holders.





On December 15, 2022, InMed Pharmaceuticals Inc., or the "Corporation", held its
Annual General Meeting of Shareholders. At the meeting, shareholders voted in
favor of all items of business, as indicated below:

Proposal No. 1-Election of Directors


The Corporation's shareholders voted to elect the following persons to the board
of directors of the Corporation, each to serve until the 2023 Annual General
Meeting of Shareholders:



                                                                     Votes          % Votes          Broker
Nominee                           Votes For       % Votes For       Withheld        Withheld       Non-Votes
Eric A. Adams                        159,223             94.90 %        8,559             5.10 %      179,813
Andrew Hull                          158,282             94.34 %        9,500             5.66 %      179,813
Janet Grove                          162,246             96.70 %        5,536             3.30 %      179,813
Bryan Baldasare                      160,764             95.82 %        7,018             4.18 %      179,813
Nicole Lemerond                      162,174             96.66 %        5,608             3.34 %      179,813





Proposal No. 2-Appointment of Independent Registered Public Accounting Firm



The Corporation's shareholders voted to approve the appointment of Marcum LLP as
the independent registered public accounting firm of the Corporation until the
2023 Annual General Meeting of Shareholders or until a successor is named.




                                                                                       Broker
Votes For       % Votes For      Vote Against      % Votes Against      Abstain       Non-Votes
   339,548          97,68%                0                  0%            8,047             0

Item 7.01 Regulation FD Disclosure.

On December 15, 2022, the Corporation issued a press release announcing the voting results of the meeting. A copy of the press release is furnished hereto as Exhibit 99.1.





The information set forth in this Item 7.01, including Exhibits 99.1, is being
furnished and shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities of that section. The information set forth in this
Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference
into any other filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such a filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



Exhibit 99.1     Press release, dated December 15, 2022
104            Cover Page Interactive Data File (embedded within the Inline

XBRL document).




                                       1

© Edgar Online, source Glimpses